Cardiomyocyte death: mechanisms and translational implications

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Although treatments have improved, development of novel therapies for patients with CVD remains a major research goal. Apoptosis, necrosis, and autophagy occur in cardiac myocytes, and both gradual and acute cell death are hallmarks of cardiac pathology, including heart failure, myocardial infarction, and ischemia/reperfusion. Pharmacological and genetic inhibition of autophagy, apoptosis, or necrosis diminishes infarct size and improves cardiac function in these disorders. Here, we review recent progress in the fields of autophagy, apoptosis, and necrosis. In addition, we highlight the involvement of these mechanisms in cardiac pathology and discuss potential translational implications.

[1]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[2]  I. Komuro,et al.  Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum–Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload , 2010, Circulation.

[3]  R. Kitsis,et al.  Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. , 2003, American journal of physiology. Heart and circulatory physiology.

[4]  C. Murry,et al.  Heart regeneration , 2011, Nature.

[5]  O. Alfieri,et al.  The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation , 2008, Circulation.

[6]  Y. Ho,et al.  Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[7]  T. Asano,et al.  Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.

[8]  W. Kremers,et al.  Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. , 2008, European heart journal.

[9]  C. Szabó,et al.  Mitochondrial-to-nuclear translocation of apoptosis-inducing factor in cardiac myocytes during oxidant stress: potential role of poly(ADP-ribose) polymerase-1. , 2004, Cardiovascular research.

[10]  R. D. de Boer,et al.  Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. , 2011, American journal of physiology. Heart and circulatory physiology.

[11]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Gottlieb,et al.  Enhancing Macroautophagy Protects against Ischemia/Reperfusion Injury in Cardiac Myocytes* , 2006, Journal of Biological Chemistry.

[13]  M. Colombo,et al.  Glucose deprivation causes oxidative stress and stimulates aggresome formation and autophagy in cultured cardiac myocytes. , 2010, Biochimica et biophysica acta.

[14]  R. Xavier,et al.  A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. , 2010, Developmental cell.

[15]  Jianxin Chen,et al.  Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. , 2001, American journal of physiology. Cell physiology.

[16]  J. Comella,et al.  Switch from Caspase-dependent to Caspase-independent Death during Heart Development , 2006, Journal of Biological Chemistry.

[17]  Guido Kroemer,et al.  Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  A. Feldman,et al.  Anti–Tumor Necrosis Factor-&agr; Antibody Limits Heart Failure in a Transgenic Model , 2001, Circulation.

[19]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.

[20]  R. Knight,et al.  STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy , 2012, Journal of cellular and molecular medicine.

[21]  Tetsuya Watanabe,et al.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.

[22]  P. Kang,et al.  Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA. , 2010, American journal of physiology. Heart and circulatory physiology.

[23]  K. Sliwa,et al.  Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. , 2002, The American journal of cardiology.

[24]  Dian J. Cao,et al.  Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy , 2011, Proceedings of the National Academy of Sciences.

[25]  Y. Ueda,et al.  Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. , 2000, Circulation.

[26]  M. Crow,et al.  Apoptosis Repressor with Caspase Recruitment Domain Protects against Cell Death by Interfering with Bax Activation* , 2004, Journal of Biological Chemistry.

[27]  G. Zambetti,et al.  Targeted deletion of Puma attenuates cardiomyocyte death and improves cardiac function during ischemia-reperfusion. , 2006, American journal of physiology. Heart and circulatory physiology.

[28]  F. Klocke,et al.  Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. , 1999, Journal of molecular and cellular cardiology.

[29]  P. Doevendans,et al.  Myocyte apoptosis in heart failure. , 2005, Cardiovascular research.

[30]  W. Manning,et al.  Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice , 2003, Circulation.

[31]  J. Gardin,et al.  Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. , 2004, Journal of the American College of Cardiology.

[32]  R. Kitsis,et al.  Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.

[33]  E. Chung,et al.  Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-&agr;, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial , 2003, Circulation.

[34]  Pablo E. Morales,et al.  [Mitochondrial dynamics: a potential new therapeutic target for heart failure]. , 2011 .

[35]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[36]  T. Mak,et al.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.

[37]  D. Offen,et al.  Bax deficiency reduces infarct size and improves long-term function after myocardial infarction , 2007, Cell Biochemistry and Biophysics.

[38]  J. McMurray,et al.  Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.

[39]  M. Mocanu,et al.  The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore , 2007, Cardiovascular Drugs and Therapy.

[40]  Lin Yan,et al.  Autophagy in chronically ischemic myocardium. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Mathur,et al.  Stem cell therapy for heart diseases. , 2011, British medical bulletin.

[42]  P. Doevendans,et al.  Downregulation of Apoptosis-Inducing Factor in Harlequin Mutant Mice Sensitizes the Myocardium to Oxidative Stress–Related Cell Death and Pressure Overload–Induced Decompensation , 2005, Circulation research.

[43]  N. Maulik,et al.  Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. , 2003, American journal of physiology. Heart and circulatory physiology.

[44]  I. Komuro,et al.  Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. , 2010, Circulation research.

[45]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[46]  T. Vanden Berghe,et al.  Molecular mechanisms and pathophysiology of necrotic cell death. , 2008, Current molecular medicine.

[47]  Yasushi Matsumura,et al.  The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress , 2007, Nature Medicine.

[48]  M. Hall,et al.  Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice , 2011, Circulation.

[49]  Y. Ho,et al.  Overexpression of BAR attenuates apoptosis and protects against myocardial ischemia/reperfusion injury in transgenic mice , 2007, Biochimica et biophysica acta.

[50]  J. Richardson,et al.  Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.

[51]  Youngil Lee,et al.  Role of apoptosis in cardiovascular disease , 2009, Apoptosis.

[52]  A. D. Campo,et al.  [Mitochondrial dynamics: a potential new therapeutic target for heart failure]. , 2011, Revista espanola de cardiologia.

[53]  H. Katus,et al.  Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. , 2009, Journal of the American College of Cardiology.

[54]  A. Quest,et al.  Cell death by necrosis, a regulated way to go. , 2008, Current molecular medicine.

[55]  H. Fliss,et al.  Apoptosis in ischemic and reperfused rat myocardium. , 1996, Circulation research.

[56]  K. Mani Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage , 2008, Heart Failure Reviews.

[57]  M. Latronico,et al.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. , 2010, The Journal of clinical investigation.

[58]  Joseph A. Hill,et al.  Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury , 2012, Circulation.

[59]  B. Sobel,et al.  Autophagy in myocardium of murine hearts subjected to ischemia followed by reperfusion , 2010, Histochemistry and Cell Biology.

[60]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[61]  So Yeong Lee,et al.  Adult alveolar epithelial cells express multiple subtypes of voltage-gated K+ channels that are located in apical membrane. , 2003, American journal of physiology. Cell physiology.

[62]  John Calvin Reed,et al.  Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[63]  K. Fukunaga,et al.  Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. , 2007, European journal of pharmacology.

[64]  Cecilia Hidalgo,et al.  Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. , 2008, Cardiovascular research.

[65]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[66]  B. Rothermel,et al.  The complex interplay between mitochondrial dynamics and cardiac metabolism , 2011, Journal of bioenergetics and biomembranes.

[67]  U. Pfeifer,et al.  Short-term inhibition of cardiac cellular autophagy by isoproterenol. , 1987, Journal of molecular and cellular cardiology.

[68]  C. di Loreto,et al.  Myocyte death in the failing human heart is gender dependent. , 1999, Circulation research.

[69]  Quan Chen,et al.  Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis. , 2005, Life sciences.

[70]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[71]  R. Gottlieb,et al.  Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy , 2007, Cell Death and Differentiation.

[72]  G. Stassi,et al.  Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. , 1999, Circulation.

[73]  J. Schaper,et al.  Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.

[74]  B. Bozkurt,et al.  Results of Targeted Anti–Tumor Necrosis Factor Therapy With Etanercept (ENBREL) in Patients With Advanced Heart Failure , 2001, Circulation.

[75]  J. Holtz,et al.  Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? , 2002, Journal of the American College of Cardiology.

[76]  Lorenzo Galluzzi,et al.  Mitochondrial membrane permeabilization in cell death. , 2007, Physiological reviews.

[77]  M. R. Bergman,et al.  Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors. , 1996, The Journal of pharmacology and experimental therapeutics.

[78]  T. Hewett,et al.  Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. , 2007, The Journal of clinical investigation.

[79]  P. Balakumar,et al.  Anti‐Tumour Necrosis Factor‐α Therapy in Heart Failure: Future Directions , 2006 .

[80]  M. Bahro,et al.  Short-term stimulation by propranolol and verapamil of cardiac cellular autophagy. , 1987, Journal of molecular and cellular cardiology.

[81]  E. Weiss,et al.  Caloric restriction: powerful protection for the aging heart and vasculature. , 2011, American journal of physiology. Heart and circulatory physiology.

[82]  Holly McDonough,et al.  Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP , 2005, The Journal of cell biology.

[83]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[84]  R. Gottlieb,et al.  Autophagy in Ischemic Heart Disease , 2009, Circulation research.